Anti-proliferative effect of LXR agonist T0901317 in ovarian carcinoma cells

BACKGROUND: Ovarian cancer is the most common cause of cancer related death from gynecologic tumors in the United States. The insidious nature of the disease precludes early diagnosis, therefore surgical debulking and chemotherapy are considered as standard treatment modalities for advanced stages....

Descripción completa

Detalles Bibliográficos
Autores principales: Rough, James J, Monroy, M Alexandra, Yerrum, Smitha, Daly, John M
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2010
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2890636/
https://www.ncbi.nlm.nih.gov/pubmed/20504359
http://dx.doi.org/10.1186/1757-2215-3-13

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2890636/
https://www.ncbi.nlm.nih.gov/pubmed/20504359
http://dx.doi.org/10.1186/1757-2215-3-13

Ejemplares similares